Persistent symptoms are difficulties that continue despite improvement or treatment. They may involve psychosis, negative symptoms, cognition, mood or anxiety. Their persistence does not identify one cause, and each domain needs assessment. A voice that remains but causes little distress has different implications from ongoing fear that prevents eating or leaving home.
Treatment resistance describes persistent clinically significant symptoms despite appropriately delivered treatment. In schizophrenia, the term usually concerns inadequate response to adequate antipsychotic trials, but definitions require attention to exposure, duration and outcomes. It should not be applied simply because recovery is incomplete or because one medicine was stopped early due to adverse effects.
Care can target both the experience and its practical impact. Psychological therapy, rehabilitation, environmental changes and treatment of coexisting conditions may help even when medication has limited additional benefit. Review should examine adverse effects that resemble symptoms, including sedation or movement-related slowing. The person’s priorities help determine which outcome matters most. A continuing symptom does not mean that no progress is possible, but it should not be dismissed simply because several medicines have already been tried.
Persistent symptoms can be described by their impact rather than presence alone. Frequency, distress, conviction and interference with activities may change differently. This allows useful goals even when complete remission is unlikely in the short term. It also supports proportionate treatment, avoiding escalation based only on a symptom’s existence without considering benefit, burden and the person’s priorities.
Further reading: Open-access research; Research record 3046553.
Comments are closed, but trackbacks and pingbacks are open.